{
  "compound": "Medical cannabis (various)",
  "condition": "GLAUCOMA",
  "effect_size": "Sustained benefit (75%)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:GLAUCOMA_OBSERVATIONAL_002",
  "participants": "52 glaucoma patients on medical cannabis",
  "year": 2020,
  "notes": "Medical Cannabis for Refractory Glaucoma: Israeli Registry Study",
  "confidence": "medium",
  "abstract": "75% maintained IOP control; Visual field progression slowed vs historical controls; Patient satisfaction 82%"
}